Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a rare subtype of non-Hodgkin's lymphoma (NHL). The aim was to evaluate response rate, progression free survival (PFS), overall survival (OS), and toxicity in PCNSL after systemic R-IDARAM and intrathecal immunochemotherapy with def...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Liren, Zhou, Chunhui, Shen, Jianliang, Cen, Jian, Yin, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041943/
https://www.ncbi.nlm.nih.gov/pubmed/27029056
http://dx.doi.org/10.18632/oncotarget.8370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041943/
https://www.ncbi.nlm.nih.gov/pubmed/27029056
http://dx.doi.org/10.18632/oncotarget.8370

Ejemplares similares